In multiple myeloma U266 cells, farnesol inhibited the activation of transcription factor signal transducer and activator of transcription 3 (STAT3), a protein involved in tumor initiation as well as progression [34] and also downregulated cell proliferation, and the expression of anti-apoptotic related proteins [34]. The gene discussed is STAT3; the disease is neoplasm.